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Perennial ryegrass (PRG, Lolium perenne) is a hardy cool-season grass that is infected 
with the endophytic fungus Neotyphodium lolii, which enables the plant to be insect 
repellant and drought resistant, lowering the use of insecticides and fertilizers. However, 
this fungus produces the compound lolitrem B (LB, m/z 686.4) which causes the 
tremorgenic neurotoxicity syndrome ‘ryegrass staggers’ in livestock consuming forage 
which contains <2000 ppb LB. Ergovaline (EV, m/z 534) is a vasoconstrictor normally 
associated with tall fescue (Festuca arudinacea), but has also been found in endophyte-
infected PRG. Past research has shown a strong linear correlation between levels of LB 
and EV in PRG. The purpose of this study was to examine the linear relationship between 
EV and LB in feces and determine common metabolites. To accomplish this,  four groups 
of steers (n=6/group) consumed endophyte- infected PRG over 70 days consumed the 
following averages of LB and EV: group I 2254ppb LB/633 ppb EV; group II 1554ppb 
LB/ 373ppb EV, group III 1011ppb LB/259ppb EV, and group IV 246ppb LB/<100ppb 
EV. Group I in week 4 was inadvertently given a washout period at which time the steers 
consumed the amount of LB and EV given to group IV (control).  Both feed and feces 
samples were extracted using difference solid phase extraction methods and quantified by HPLC-fluorescence for LB and EV. Concentrations of EV and LB obtained through 
HPLC-fluorescence in both PRG and feces showed a linear relationship. Additional 
screening for metabolites was conducted LC-MS/MS and showed possible oxidation and 
reduction metabolites for both toxins. 
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CHAPTER 1. INTRODUCTION 
1.1 General Introduction 
  Ergovaline and Lolitrem B are two alkaloid toxins commonly known in large 
animal medicine, specifically cattle. These two compounds originate from endophyte 
fungus in perennial ryegrass (PRG). Ergovaline (EV) is normally associated with tall 
fescue, however it is also found in endophyte infected perennial ryegrass. EV is a 
vasoconstrictor and can cause gangrenous clinical signs as well as reproductive issues for 
cows. Lolitrem B is potent neurotoxin which causes ‘ryegrass staggers’ in cattle and other 
animals. The long term effects and metabolic implications are not completely understood 
with LB in combination with ergovaline. Hovermale et al. (2001)  showed that these two 
compounds exhibit a linear relationship in PRG but no clinical signs of EV toxicity are 
seen when both EV and LB are consumed at toxic levels. The reason for this is not well 
understood and understanding how these two toxins are metabolized and excreted may 
help veterinarians treat both clinical diseases in cattle and other animals.   
 
1.2 Aim and Objectives 
  The present study aims to determine the correlation of  EV and LB excreted in the 
feces of steers fed PRG by quantifying both compounds in fecal samples by HPLC-
fluorescence and identifying possible metabolites by LC-MS/MS analyses. The objective 
was to provide a better understanding on clinical disease in bovine species that consume 
PRG and help better understand the fate and metabolism of LB which is largely 
unknown. 2 
 
 
1.3 Outline of Thesis 
  The thesis consists of five chapters. Chapter 2 is the literature review which 
focuses on general properties of EV and LB. The structure, chemistry, sources, and 
metabolism of both compounds are discussed as well as analytical procedures common 
for analyzing both compounds in plant and animal matrices. Chapter 3 covers materials 
and methods for the animal study and analytical procedures used for the data that resulted 
in chapter 4. Chapter 4 discusses the findings of EV and LB in bovine fecal samples 
along with LC-MS/MS data of possible metabolites. Chapter five provides a discussion 
and conclusion of the present study and the contribution to our knowledge of endophyte 
diseases in cattle.  
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CHAPTER 2. LITERATURE REVIEW 
Parts of the section Analytical Procedures were published in Recent Advances in 
Phytochemistry: Phytochemicals, Plant Growth, and the Environment, Vol. 42, Chapter 
3: Endophyte Mycotoxins in Animal Health., 2012. 
 
2.1. General properties and toxicity of ergovaline 
2.1.1 Structural and chemical properties 
EV is part of a larger group of secondary fungal metabolites known as ergot 
alkaloids. These compounds all share a common ergolene ring and a tricyclic peptide 
portion of the molecule [1, 2].  The common ergopetine structure is shown in figure 2.1 
with important carbons labeled that are key in chemical transformations of ergot 
alkaloids. Ergot alkaloids are colorless crystals and readily soluble in various organic 
solvents; however,  insoluble or only slightly soluble in water. Ergots which contain the 
double bond at C-9 and C-10 rapidly epimerize with respect to the centre of symmetry at 
C-8.  
Biological and physiochemical properties vary between the C-8 epimers. From 
pH 4.8 for ergocorninine to pH 6.2 for ergometrinine. They are positively charged at the 
N-6 position in the ergoline ring when under acidic conditions [1].  4 
 
 
Figure 2.1 Common structure of ergopeptine compounds [1, 3].  
 
2.1.2 Formation and Sources  
Ergovaline is a compound that is produced in tall fescue or perennial ryegrass by 
the genus Claviceps purpurea. It is an ergopeptine and falls in the group of ergot 
alkaloids that are commonly associated with tall fescue. Tall fescue originated from 
Western Europe and most likely came to the United States as a seed contaminant. The 
most common cultivar in the US is the “Kentucky 31” which was released commercially 
in 1942. Soon after commercial release, this grass was very popular because of its 
tolerance to adverse weather conditions, pest resistance, and high protein levels. Tall 
fescue is grown best in temperate climates like that of Oregon [4]. 
 
 5 
 
 
2.1.3 Animal Toxicity 
Ergovaline has been a common problem since the increase in the use of tall fescue 
grass for animal forage early in the 1940’s. Soon after the popularity of the grass 
increased, the “fescue problem” began. Clinical signs of EV and ergot alkaloid toxicity 
can be classified into three categories. First, during lower temperatures during winter 
months “fescue foot” was noticed in livestock. This is a gangrenous condition seen in feet 
and or tails of affected animals. Secondly, fat necrosis has been shown in animals that 
consumed high endophyte tall fescue forage. This condition is caused by hard fat masses 
in adipose tissue forming around intestines and causing digestive upset and reproductive 
problems. This clinical sign of fescue toxicosis lead early researchers to investigate the 
influence endophyte toxins had on lipid metabolism in animals. The third category of 
clinical signs is called “summer slump” which is a period during warm temperatures 
when animals show poor weight gain, intolerance to heat, excessive salivation, rough hair 
coat, elevated body temperatures, nervousness, lower milk production, and reduced 
conception rate. For example, cattle experiencing summer slump may lay in mud puddles 
or under shade for the majority of the day[4, 5].   
The mechanism of toxicity for EV was not well understood until the early 1990s. 
Porter et al. (1990) showed that endophyte infected feed altered dopaminergic and 
serotonergic metabolites after steers consumed the infected feed. The precursor to this 
study was the findings in Berde (1978) that endophyte consumption was known to reduce 
serum prolactin levels. Prolactin secretion is known to be inhibited by dopamine but 6 
 
increased by serotonin. A common test is to measure serum prolactin levels to determine 
exposure to EV or other ergot alkaloids [6, 7]. It was not until Dyer 1993 that evidence of 
EV acting on serotonin receptors was published [5, 8]. 
 
2.2 General properties and toxicity of Lolitrem B 
2.2.1 Structural and chemical properties 
The lolitrem compounds belong to a class of compounds known as indole-
diterpenes. These compounds are from a large class of compounds from the fungal 
secondary metabolites of Trichocomaceae (Aspergillus and Peniciliium spp.) and 
Clavicepitaceae (Neotyphodium/Epichloe and Claviceps spp.). Lolitrem B is also 
considered a paxilline like compound and is often studied simultaneously with paxilline 
[9]. These compounds while diverse all share a common moiety of a cyclic diterpene 
skeleton (paxilline) core and an indole group shown in figure 2.4 [10, 11]. The rings A 
and B represent the indole core and rings C-F represent the diterpene skeleton common to 
lolitrem compounds.  
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Figure 2.2. Lolitrem Compounds. Strucutre of paspaline, paxilline and lolitrem with the indole and 
diterpene core structures labeled as rings A-F. The structure of paspaline indicates likely sites of enzymatic 
conversions proposed in Saikia et al. 2008 [11]. 8 
 
This core structure specifically on paspaline is the precursor, is where enzymatic 
conversions are likely to occur in biosynthetic pathways of more complex indole-
diterpenes [11].  
2.2.2 Formation and Sources 
  Lolitrem B along with other lolitrem compounds is a potent neurotoxin produced 
by the endophytic fungus Acremonium lolii L. and is present in PRG  (lolium perenne L.) 
[12, 13]. PRG is common in New Zealand and Oregon because it is easily adaptable to a 
wide range of soils and climate conditions. It is a persistent crop which also serves as a 
good nutritive forage for livestock. The presence of endophyte fungus in PRG allows the 
grass to be insect resistant causing enhanced plant growth and prevents overgrazing by 
herbivores [14].   
2.2.3 Animal Toxicity 
  In livestock animals consumption of PRG can lead to a condition known as 
“ryegrass staggers” which was first reported in 1880 in New Zealand. The clinical signs 
reported were ataxia and tremors. Animals show impaired motor coordination and can 
cause significant management issues and animal losses [15]. Other clinical signs are 
headshaking, abnormal staggering gait, and stumbling, collapsing, and severe muscle 
spasms. These clinical signs can take 7-12 days to occur in sheep and cattle [16]. Clinical 
signs of ryegrass staggers usually follow seasonal patterns and show the highest 
occurrences in late summer and early fall. Mortality is not usually from the consumption 
of PRG but attributed to drowning  in creeks, fractures limbs, or falls due to the 
staggering that PRG causes [14, 16].  9 
 
Lolitrem compounds were later isolated and determined the causative agent of 
“ryegrass staggers.” These compounds show long duration of actions and usually 
completely reversible neurological effects. Other physiological effects such as increased 
blood pressure, heart rate and respiration rate all suggested that LB affects large 
conductance calcium activated potassium ion (BK) channels[17]. Paxilline has been 
shown to inhibit the large conductance calcium activated potassium ion channels and is 
commonly studied with LB because of structural and mode of action similarities [17]. To 
determine the mechanism of toxicity by LB, Dalizel et al. (2005) used patch clamping 
and embryonic human kidney cells to look at the α subunit of BK channels and the 
effects of LB. This study did show that LB inhibited the α subunit. However, the question 
still unanswered in this study was whether the inhibition was happening in the central 
nervous system (CNS) or directly on muscles.  
Imlach et al. (2008) was able to determine which β subunit lolitrem B inhibited 
and answer the question posed in Dalizel et al. (2005) whether the inhibition was 
occurring at the CNS or by direct effect on muscles [15]. Since the α subunit of BK 
channels is diverse and present in many tissues it is paired with one of four β subunits. 
They are present in smooth muscle, ovaries, testis, and neural tissues and labeled β1-4 
respectively. Imlach et al. (2008) tested their hypothesis by using mice deficient in either 
β1 or β4 to determine exactly where LB inhibits BK channels. This study found that LB 
toxicity requires the β-4 subunit present in the neural tissues. Interestingly, LB was 
shown to have five times the affinity for the BK channels than paxilline did. LB was also 
shown to have a longer duration of action than paxilline. [15]. 10 
 
2.3 Analytical Procedures 
2.3.1 Extraction from Plant Material 
Initially, LB was extracted by multiple liquid-liquid extractions and further 
purification was accomplished using column chromatography with silica gel, reversed 
phase thin layer chromatography and analytical HPLC [18]. The first large-scale isolation 
of LB used ground perennial ryegrass seed [19] and a series of solvent extractions 
including petroleum ether, alcohol, acetonitrile, water, and dichloromethane (DCM). The 
final step involved flash chromatography using the same solvents. Another method for 
the purpose of LB quantitation involves liquid-liquid extraction and filtering before 
HPLC analysis [20].  
Current methods for extraction and quantification of ergot alkaloids in plant 
material are based on previous studies [21, 22], for subsequent analysis by HPLC-
fluorescence or LC-MS/MS. Seed and straw samples are ground in a Cyclotec 1093 
sample mill and passed through a 0.5 mm screen. One gram of the ground plant material 
is weighed into a glass screw-top tube. To each tube of sample, control or reference 
material (as neat standard is expensive and difficult to synthesize, ground seed or straw is 
mixed in large batches at four target concentrations to generate material for use in a 
standard curve. The curve is validated using >98% pure ergovaline (Forrest Smith, 
Auburn University)), 10 ml of chloroform plus 1 ml internal standard (1 µg/ml 
ergotamine in chloroform) and 1 ml 0.001 N NaOH are added to deprotonate ergot 
alkaloids that may have been protonated in acidic conditions. The tubes are capped and 
mixed for 18-24 hours in the dark, then centrifuged at 1,700 x g. Five ml of organic 11 
 
supernatant from the centrifugation step is applied to solid phase extraction (SPE) 
columns containing Ergosil® and anhydrous sodium sulfate. EV is extracted by 
conditioning with chloroform, followed by a 3:1 chloroform:acetone (v/v) wash and 
elution with 2.5 ml methanol. The eluent is dried under nitrogen at 50°C, then 
reconstituted in 0.5 ml methanol. Samples are mixed for 10 seconds, sonicated for 10 
seconds, and centrifuged at 913 x g for 5 minutes. Samples are transferred to amber 
HPLC vials and sealed for analysis. The percent recovery for this method is 91% for seed 
and plant material. Inter-assay and intra assay variations are 5.7% and 3.8%, respectively.   
 
2.3.2 Extraction from Animal Matrices 
The best method for extracting EV from animal matrices (blood, feces, urine and 
ruminal fluid) involves clean-up with silica-based C-18 SPE columns. When extracting 
for EV, tissue matrices are typically pre-treated with a dilute base to ensure optimum 
recovery, as treatment with strong acids or bases will completely hydrolyze the amide 
bond. Jaussaud et al. (1998) reported recovery rates from 90-102% for EV extracted out 
of ovine plasma using a sodium hydroxide pretreatment and a liquid-liquid extraction 
with diethyloxide. EV can be extracted from dried feces following the same methodology 
used for plant material [21, 23]. Extraction of EV from urine and ruminal fluid can be 
performed by placing it in chloroform buffered with K3PO4 and adding ergotamine as an 
internal standard, then rotating for 5 hours in the dark. The supernatant is then added to 
an Ergosil® SPE column, and extracted as described above for plant material. The final 12 
 
ruminal fluid extract is dried under nitrogen and reconstituted in methanol for analysis by 
HPLC.   
While chlorinated solvents are best for extracting LB from grass and seed, 
Miyazaki et. al. (2004) was able to use a 9:1 (v/v) hexane:ethyl acetate solvent mixture 
for extracting LB from bovine fat and other tissues, followed by a 9:1 (v/v) hexane:ethyl 
acetate pre-wash and wash on Sep-Pak Plus Silica SPE columns (Waters, Milford MA), 
with elution using a 7:3 (v/v) hexane:ethyl acetate solution. The eluent was dried under 
nitrogen and reconstituted in 85:15 DCM:ACN before analysis via HPLC-fluorescence 
and HPLC-MS. Our group has successfully used this extraction procedure for bovine 
feces and a similar method for extracting LB and its metabolites from bovine urine. LB 
quantification in bovine feces is also possible using the same extraction method described 
above for quantitating LB in plant material [20].  
     With the extraction methods detailed above for ergovaline and lysergic acid in blood, 
feces, urine and ruminal fluid and LB in fat, tissues, feces and urine, detection of 
endophyte mycotoxins in animal matrices is possible and can be used as a diagnostic tool 
to confirm cases of endophyte toxicosis. For example, the feeding trials conducted in 
sheep, cattle and horses found fecal ergovaline and urinary lysergic acid to be the primary 
excretory products formed [23-25]. From these studies we can conclude that a fecal 
sample extracted for ergovaline and a urine sample extracted for lysergic acid would be 
the best tools for clinical diagnosis of fescue toxicity. Studies like these are still needed 
for LB in order to determine the best matrix and extraction method to use as a tool for 
diagnosis of ryegrass staggers.  13 
 
2.3.3 HPLC-Fluorescence Analysis of Endophyte Mycotoxins 
The current protocol for HPLC analysis of ergovaline involves reverse phase 
chromatography with fluorescence detection (excitation and emission wavelengths of 250 
nm and 420 nm, respectively) and a gradient pump
 program using ammonium carbonate 
in aqueous acetonitrile and acetonitrile as mobile phases. Additional methods of analysis 
can be found in Hovermale (2001) and Craig (1994). 
     Using the TotalChrom data system (Perkin Elmer, Waltham MA), a standard curve 
can be constructed from reference plant material of concentrations around 100, 400-500, 
900-1000, and 2000 ng/g of plant material. The concentrations of plant material can be 
determined using purified standards; however, using plant material for day to day 
operations provides a cost benefit and allows for lower cost of analysis. A linear 
regression fit of the peak area versus the amount of analyte injected is used to determine 
the amount of ergovaline in unknown samples. The limit of detection (LOD) is 31 ng/ml 
and the limit of quantitation (LOQ) is 100 ng/ml for forage samples. The LOD for 
ergovaline in rumen fluid is 10 ng/ml. While this method may be sufficient for analysis of 
plant material for regulatory purposes, it is not sufficient as a research to tool to 
determine total distribution and metabolism of ergovaline in a feed study with livestock 
where analysis of body matrices requires a much lower LOD/LOQ. For example, 
ergovaline was previously extracted from plasma by two groups using a liquid 
diethyloxide extraction and subsequently quantitated by HPLC-fluorescence; they 
determined their LOQ to be 3.5 ng/ml [26] and LOD to be 1.2 ng/ml [27]. Both 
extractions required a large amount of sample (4 mL plasma) and, while they were good 14 
 
for determining the kinetic properties of EV after a single intravenous dose, the actual 
amount of EV ingested by livestock on a daily basis in typical feeding experiments would 
not be detected or quantified, based on data which found actual serum levels of 
ergovaline to be 0.7 – 3.8 pg/ml (pregnant mares grazing on endophyte infected tall 
fescue pastures with a daily dose of approximately 1 mg/day ergovaline) [28]. Instead, 
Lehner et. al (2008) assayed their sera by LC-MS/MS which had a LOQ of 1 pg/ml. We 
review the usefulness of LC-MS/MS for these types of samples below. Based on these 
studies, we also suggest that better data may come from analyzing serum, instead of 
plasma, as there will likely be less interference since the blood has already been allowed 
to clot, allowing any unnecessary components to be removed. 
     Additionally, HPLC-fluorescence can be used where separation and purification of 
mixtures of ergot alkaloids and their metabolites are needed, particularly before use of 
instrumentation such as high resolution mass spectrometry. For example, this technique 
was used to isolate metabolic products from ergotamine incubations in mice [29]. 
Isolation of ergotamine, its epimer, and seven transformation products was accomplished 
by manual peak collection via monitoring on a photodiode array detector (254 nm), 
clean-up of the incubation matrix on C18 SPE cartridges, dry down under nitrogen and 
reconstitution in methanol before analysis by mass spectrometry.  
LB quantitation by HPLC-fluorescence detection uses normal phase separation 
and an isocratic mobile phase (DCM:ACN:H2O 4:1:0.02 (v/v)) run at 0.5 ml/min for 15 
minutes [18, 30] . LB is detected using a fluorescence detector set with an excitation 
wavelength of 268 nm and an emission wavelength of 440 nm. A Zorbax RX-SIL, 5 µ, 15 
 
4.6 x 250 mm analytical column (Agilent Technologies, Santa Clara CA) is used in 
conjunction with a hand packed silica guard column. The retention time of lolitrem B is 
8.3 minutes. Using the TotalChrom data system, a standard curve is constructed from 
reference material of concentrations around 500, 900, 2000, and 4000 ng/g of plant 
material. A linear regression fit of peak height versus the amount of analyte injected is 
used to determine the amount of lolitrem B in unknown samples. The LOD is 30 ng/ml 
and LOQ is 100 ng/ml for plant material. HPLC-fluorescence is sufficient for regulatory 
purposes but the metabolism of LB is still largely unknown, and expensive analytical 
standards are necessary for quantifying LB in a variety of matrices. Like EV, this will 
require the sensitivity and specificity of analytical tools like LC-MS/MS.  
 
2.3.4 Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS) Analysis  
A need exists for a fast, highly specific, highly sensitive method of detection for 
ergot alkaloids which can be easily utilized in a variety of matrices. In recent years, LC-
MS/MS has become a prominent tool for identifying and quantifying ergot alkaloids. It 
capitalizes on these characteristics, specifically, electrospray ionization in the positive ion 
mode (ESI (+)) using multiple reaction monitoring (MRM). Detection of  EV is best done 
by MRM because the fragmentation pattern of the product ions is similar for most of the 
commonly tested ergot alkaloids (Table 2.1). The most common product ions produced 
are m/z 208 and 223 (Figure 2.2), representing the lysergic acid and demethylated 
lysergic acid moieties, respectively [31]. Representative spectra of the two main 
compounds associated with fescue toxicosis (EV and lysergic acid), and LC-MS/MS 16 
 
conditions used in our laboratory, are presented in Figure 2.2. Analysis of ergot alkaloids 
in food products by LC-MS/MS have LOQs of 0.17-2.78 ng/g and LODs of 0.02-1.2 ng/g 
[1], up to three orders of magnitude below those of HPLC-fluorescence. 
     When using LC-MS/MS to detect and quantify ergot alkaloids, two major variables 
must be considered: (1) pKa values of 4.0 to 6.2 dictate that amines of rings 2 and 4 
(Figure 2.2A) be charged in acidic solution and neutral at alkaline pH. Thus, it is 
common practice to use weak volatile bases in the mobile phase to enhance detection 
[32]. Mobile phases similar to those described for HPLC-fluorescence are sufficient for 
mass spectrometry analysis. (2) Ergot alkaloids form epimers that do not necessarily 
fragment consistently (Table 2.1) [33]. In particular, some epimers may favor a different 
fragment, such as ergometrinine which favors the m/z 208.2 over the m/z 223.2 fragment. 
Epimers also increase in concentration the longer they are suspended in organic solvents 
or held at room temperature. For instance, EV was shown to epimerize at 37°C in 0.1 M 
phosphate buffered 9% aqueous fetal bovine serum solutions, and in water, methanol, and 
acetonitrile, reaching an epimerization equilibrium between 1-19 hours [34]. Further, 
ergot alkaloid epimers generally chromatograph separately from their non-epimerized 
counterparts [29, 35], thereby eliminating part of the total concentration in the original 
sample to be measured, resulting in concentrations lower than what the sample truly 
contains. To this end, epimer formation can cause major variability in quantitation by 
affecting peak areas and intensity as well as retention times if analyzing standards or 
samples that have been suspended in solvents for an extended period of time. Therefore, 
it is of paramount importance to keep this in mind when handling standards and samples, 17 
 
and in performing experiments where animals are dosed using a liquid solution of these 
toxins.    
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Figure 2.3. ESI(+)-enhanced mass spectrometry spectra of ergovaline prepared in a 50:50 (v/v) mix of 2 
mM ammonium carbonate and acetonitrile (a) and D-lysergic acid prepared in acetonitrile (b). Methods: A 
positive enhanced mass spectra scan was performed using a 3200 QTRAP hybrid triple-quadrupole/linear 
ion trap mass spectrometer (Applied Biosystems/MDS Sciex, Foster City CA) with a Turbo V electrospray 
ionization source operated at 600°C, ion spray voltage of 5.5 kV, declustering potential of 61 V and a 
collision energy of 10 eV. A linear gradient (0-100% B over 30 min, holding for 10 min at 100%B, and 
(A) Ergovaline 
(B) Lysergic acid 18 
 
equilibrating for 10 min at 100% A) of 30% acetonitrile, 2 mM ammonium carbonate in water (mobile 
phase A) and acetonitrile (mobile phase B) was run on a 2.6µ, C18, 100Å, 100 x 4.60 mm Kinetex column 
using a flow rate of 1.4 mL/min. For (a), the common ergot fragments of m/z 149, 208, 223, 249, 269, 277, 
320, 488, 516 are visible, as seen in Lehner et. al (2004 and 2005). For (b), the common ergot fragment m/z 
208 is visible, as is the parent m/z of 268. 
 
Table 2.1. Precursor and product ions used in MRM analysis of commonly tested ergot alkaloids.
a 
Analyte 
Precursor Ion 
(m/z)
b 
Product Ion 
(m/z) 
Lysergol  255.1  240.2, 197.2 
Ergine  268.1  223.2, 208.2 
Lysergic Acid  269.3  223, 167, 44 
Ergometrine  326.2  223.2, 208.2 
Ergovaline  534.2  223.2, 208.2 
Ergosine  548.4  223.2, 208.2 
Ergocornine  562.2  223.2, 208.2 
α-Ergocryptine  576.4  223.2, 208.2 
Ergotamine  582.2  223.2, 208.2 
Ergocristine  610.4  592.4, 223.2 
aAdapted from Lehner et. al, 2004 and Sulyok et. al, 2007. 
bAll precursor ions are given as the [M+H]
+ ion.  
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(A)   
(B)    
(C)  
Figure 2.4. General Ergot Alkaloid Peptide Structures. (A) Typical fragmentation pattern for ergot 
alkaloids that contain the general peptide structure (ergovaline, ergotamine, ergocornine, ergocryptine, 
ergocrystine, and ergonovine). (B) Lysergol and lysergic acid give slightly different fragmentation patterns. 
(C) Ergometrine and ergine show the same fragmentation pattern of m/z 223 and m/z 208, but do not have 
the same general peptide structure as represented in (A). Adapted from Lehner et. al (2004).  
 20 
 
Currently, mass spectrometry by positive atmospheric pressure chemical 
ionization (APCI (+)) is the ionization mode of choice for analysis of LB [36]; it has also 
been used to identify the LB biosynthesis pathway in plants and new lolitrem-like 
compounds [37]. A Phenomenex Prodigy ODS (30), 5 µ, 150 x 4.6 mm column was used 
with mobile phases consisting of 40% aqueous acetonitrile, 0.1% acetic acid (A) and 
acetonitrile, 0.1% acetic acid (B) run at 1 ml/min using a gradient beginning with 20% B, 
rising linearly to 50% B at 20 min, then to 100% B at 40 min and recycling after 60 min 
[37]. The mass spectrometer was operated with nitrogen sheath and auxiliary gas set to 
40 and 10 psi, respectively. Source voltage was 6 kV, capillary temperature was 200
oC, 
and vaporizer temperature was set to 450
oC. For metabolite mining, an EMS scan is 
performed using the full-length, 60 min gradient described in Young et. al (2009) (Figure 
2.4).  
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Figure 2.5. APCI(+)-EMS spectrum of lolitrem B standard prepared in ACN. Methods: A positive 
enhanced mass spectrometry (EMS) scan was used to acquire this spectra on a 3200 QTRAP hybrid triple-
quadrupole/linear ion trap mass spectrometer with a Turbo V atmospheric pressure chemical ionization 
(APCI) source operated at 450°C and nebulizer current of 6µA, using a declustering potential of 20 V and a 
collision energy of 10 eV. LC conditions from Young et. al (2009) were used with the exception of flow 
rate, which was 0.5 ml/min. Common fragments specific to lolitrem B are m/z 576, 602, 628, 686 [37-39] 
 
2.4 Ruminal Metabolism 
2.4.1 Ergovaline and Ergot Alkaloids 
Bovine species are unique in the fact that they have a rumen which houses 
microogranisms that are capable of metabolizing toxins and thus sometimes making 
ruminants less susceptible to toxins [40]. Metabolism of EVis still being studied however 
some researchers have been able to generalize the effects of ergot alkaloids on cattle 
metabolism. One study in an attempt to better understand ergot metabolism found total 
ergot concentrations to be mostly in the duodenum (67%) and the feces (~24%) while no 
ergot alkaloids were detected in milk or blood. It was also postulated here that the pH of 
the rumen may play an important role in metabolism by causing the ergots to transform to 
their respective –inine isomers which are less pharmacologically active and therefore less 
toxic [41]. The pH of the rumen is slightly acidic (5-6) which does make this highly 
probable [42].  
  Cattle liver incubations with ergotamine showed through HPLC that the parent 
molecule was converted to more hydrophilic molecules but also decreased over time 
suggesting further metabolism. These hydrophilic molecules were identified as mono and 22 
 
di-hydroxylated metabolites that were hydroxylated on the peptide structure of the parent 
molecule. In these incubations dexamethasone, a CYP3A inducer, was also used 
suggesting CYP3A has a role in detoxifying ergot alkaloids [35]. 
  Settivari et al. (2006) later identified the genes specifically associated with 
endophyte infected feed that are responsible for detoxification and antioxidant activity in 
rat liver. This study showed that CYP2C13 and CYP2E1 were upregulated as well as 4-
hydroxyphenlypyruvic acid dioxygenase, NADH dehydrogenase, epoxide hydrolase, 
catalase, and tryptophan 2,3-dioxygenase. All of these genes play a key role in 
detoxification of xenobiotics and were all upregulated in the presence of ergot alkaloids. 
Interestingly, glutathione synthetase responsible for glutathione biosynthesis was down 
regulated [43]. Conversely, a study by Tanaree et al. (2012) found bovine species showed 
up regulation of glutathione S-transferase M1 [44]. This suggests key differences in 
species when faced with ergot metabolism.  
Loline alkaloids are a class of compounds produced by the same fungus that 
makes EV and LB. However, these compounds are saturated pyrrolizidines that are very 
unusual in structure with an ether linkage that connects two bridge head carbon atoms. 
Lolines have not been implicated as toxins in livestock but as potent insect replant found 
in grasses. Gooneratne et al.,(2012) studied the excretion of loline alkaloids  in urine and 
feces of sheep. However, this study found that there was only a small amount excreted in 
the feces, but this could have also been from interference of multiple compounds that 
eluted at the same time as known lolines. Total loline excreted in the feces was estimated 
at 9.9%. Authors also stated this recovery was probably underestimated [45]. N-acetyl 23 
 
loline has been suggested to enhance the effect of EV on cattle [45]. Klotz et al. (2008) 
showed that alone, neither N-acetylloline or lysergic acid produced contraction responses 
in bovine lateral saphenous veins. However, upon addition of EV, a vasconstricive 
response was generated when in combination with either N-acetylloline or lysergic acid. 
The responses of the single doses of toxins versus the mixtures was different. Therefore 
there exists additive properties of alkaloids. However, there is still no documented 
synergistic evidence of alkaloids with different mechanisms of action like those of the 
lolitrems and ergopeptides.   
 
2.4.2 Lolitrem B and Indole Compounds 
Research into the exact genes that are upregulated or downregulated with respect 
to LB are to our knowledge unknown. LB has been shown to accumulate in the fat tissue 
of both sheep and cattle [30, 46]. However, toxicokinetic data on LB is limited, and 
investigations into the enzymes responsible for metabolism of the parent molecule have 
not been conducted. However, since LB does belong to the indole class of compounds, 
this section aims to examine the metabolism 3-methylindole (3-MI) which is toxic to 
ruminants and has been heavily studied.  
An indole compound commonly associated with ruminant lung toxicity is 3-
methylindole which is derived from dietary tryptophan during ruminant fermentation. 
Cytochrome P450 monooxygenases are the main enzyme responsible for the bio- 
activation of 3-MI to its toxic intermediate. Conversely, the major route of detoxification 
of 3-MI has been proposed as through glutathione conjugation through formation of a 24 
 
electrophilic imine methide intermediate which can also trap water and tautomerize to 3-
methyloxindole, a urinary metabolite [47].  
 
Figure 2.6. Metabolism of 3-methylindole by ruminal species proposed by Nocerini et. al (1985) [47]. 
  Lanza et al. (2001) showed that 3-MI was metabolized by a number of CYP450 
enzymes, but in very specific routes. CYP 1A1 and 1A2 both were found to produce the 
dehydrogenation, oxidation, and indole 3-carbinol metabolites. CYP 2F1 and 2F3 were 
found to selectively produce the dehydrogenation metabolites. CYP1B1 was shown to 25 
 
produce I3C and 3MOI (shown in figure 2.7). CYP 2A6, 2C19, and 2D6 were shown to 
produce I3C and 3MOI. CYP 2B6, 3A4, and 3A5 only produced 3MOI. Interestingly, 
CYP2E1 was shown to selectively produce 3MOI, which is also a common upregulated 
CYP450 in ergot alkaloid metabolism [43, 48]. 
 
Figure 2.7. Proposed metabolism pathway of 3-MI by CYP450 enzymes. 3-methyleneindolenine was 
unstable and determined after trapping with NAC [48].  
 
In an unpublished study conducted at our laboratory, a microarray of the liver 
samples collected from the same study that was used to analyze fecal samples for LB and 
EV, showed 6 potential biomarkers for perennial ryegrass toxicosis: stearoyl-CoA 
desaturase, acyl-CoA synthesase short-chain family member 2, glutathione peroxidase 4, 
diazepam binding inhibitor GABA receptor modulator, arginase (liver), and LAG 26 
 
homolog ceramide synthetase 6. Gene ontology showed that oxidation and reduction 
genes were upregulated in all groups which suggests CYP450 activation. Additionally, 
lipid, cholesterol, and sterol biosynthetic pathways were shown to be upregulated. 
Additionally ceramide synthesis was shown to be upregulated in the presence of LB. 
However, since EV was measured in this experiment it is not known whether the genes 
being upregulated for fatty acid synthesis are from EV or a combination of the two toxins 
[49]. The influence of glutathione in the detoxification of EV and LB when consumed 
together has not been studied as a possible explanation to why only LB clinical symptoms 
are seen and not EV.  Settivari et. al. (2006) indicated that glutathione synthetase was 
down regulated in rat liver genomic analysis. This gene is responsible for glutathione 
synthesis, oxidoreductase activity, cholesterol biosynthesis, and lipid metabolism [50]. In 
Tanaree et al. (2012), a study with four bovine species found that there was an 
upregulation of glutathione S-transferase M1. This gene is responsible for the 
detoxification of xenobiotics through conjugation with glutathione [44]. Li et al (2012) 
found an upregulation of glutathione peroxidase 4 and upregulation of ceramide 
biosynthesis. Ultimately gluthathione metabolites could help answer questions pertaining 
to the influence of glutathione on metabolism of LB and EV. There is obviously a 
difference in metabolism between species which can offer an explanation to the clinical 
disease signs shown when both toxins are consumed.  
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2.4.3 Additional characteristics of ruminal metabolism 
  Ruminants possess characteristic metabolic properties because of the rumen 
which houses a consortium of anaerobic microbes that possess the ability to detoxify a 
number of compounds. However, ovine and bovine have been shown to possess different 
capabilities for metabolizing toxins. Wachenheim et al (1992) showed that the ovine 
rumen was significantly different from the bovine rumen when forced to metabolize 
pyrrolizidine alkaloids (PA) found in tansy ragwort (Senecio jacobaea). This was 
demonstrated by infusing PAs directly into the liver of sheep which showed the same 
clinical disease signs when PAs were consumed by cattle[51]. Rumen microbiota was the 
key component to sheep being more resistant to PA toxicity. By HPLC-fluorescence this 
was further exemplified by conducting in vitro experiments with whole rumen fluid 
(WRF) from sheep, goats, and cows. The sheep showed that PAs disappeared after 4 hrs, 
goats after 3hr, and cow WRF took 19hrs to transform PAs [52].  
  Structural similarities between the pyrrol ring in PAs and the rings of nitro-
aromatic compounds led researchers to investigate the degradation capacities of ovine 
ruminal microbes as a possible tool for bioremediation. De Lorme et. al., (2009) showed 
that seven out of twenty-one ruminal bacteria species were capable of degrading TNT. 
However, one aspect lacking in this study was LC-MS/MS data to determine if ring 
cleavage was occurring. Eaton et al (2011) showed that ovine ruminal microbes were also 
capable of degrading RDX, another explosive compound known to contaminate multiple 
military sites across the country. Similar to the TNT experiment, the results for RDX 
degradation experiments lacked LC-MS/MS data and any indication of the types of 28 
 
metabolites being formed. Not until Eaton et al (2012) was LC-MS/MS data obtained and 
it was concluded that RDX was being metabolized by ovine ruminal microbes to nitroso 
intermediates MNX, DNX, and TNX. Additionally, an ion of m/z 149 was proposed as 
ring cleavage product as a result of the intermediate metabolite MEDINA[53, 54].  
  The differences seen in metabolism of sheep versus cattle shows that the rumen 
and the certain microbes present play a key role in metabolism and may offer a better 
understanding of toxic mixtures when considering the synergistic properties of LB and 
EV. There is sufficient evidence from enzyme and genomic studies conducted with ergot 
alkaloids and 3-methylindole that similar routes of excretion and metabolism may be 
happening in the gastrointestinal tract and circulatory system. This study aims to better 
understand why clinical signs of LB are seen and not EV while both are consumed at 
toxic levels.  
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CHAPTER 3. Materials & Methods 
3.1 Chemicals and Equipment 
HPLC and LC-MS/MS grade acetonitrile, methanol, dichloromethane, chloroform 
and reagent grade ammonium carbonate were purchased from J.T. Baker (Phillipsburg, 
N.J.). Lolitrem B analytical standard was purchased from AgResearch Limited, Ruakura 
Research Centre (Hamilton, New Zealand). Ergotamine tartrate was purchased from 
Sigma-Aldrich (St. Louis, MO). Ergovaline tartrate analytical standard was purchased 
from and prepared by Dr. Forrest Smith, Department of Pharmaceutical Sciences, Auburn 
University (Auburn, AL).  
 
3.2 Animals and treatment 
A detailed experimental design can be found in Blythe et al., (2012). Briefly, 24 
steers under one year of age, with an average weight of 348kg, were purchased from 
commercial feedlots in Oregon. Animals were castrated and treated with anthelmnthics 
prior to shipping. Upon arrival, steers were placed onto pasture for 10 days with open 
access to the barn and water. All twenty four steers were initially placed onto pasture for 
10 days with open access to the barn.  During this time steers were examined by a 
veterinarian and those affected were treated for dermatophytosis (ringworm), infectious 
bovine keratoconjunctivitis (IBK, pink eye) and bovine respiratory disease (BRD)  or 
“shipping fever.” Following this initial acclimation period they were randomly separated 
into 4 pens of 6 steers each. Steers were allowed one week to adjust to a perennial 
ryegrass straw (LB <300ppb) diet prior to the start of the study.  30 
 
Animals were fed twice daily ad libitum for the duration of the experiment with 
open access to water and mineral blocks. Feed samples and orts were taken each day, 
dried, and stored at -20°C until analysis of LB and EV concentrations as described below.  
During each fecal sample collection steers were weighed using a scale built into the 
chute. All procedures were approved by the Institutional Animal care and Use Committee 
at Oregon State University (IACUC #4031). 
 
3.3  Perennial Ryegrass 
Endophyte infected PRG was obtained at various concentrations of lolitrem B.  
Four rations were formulated to different concentrations. Group I was designated as high 
group which was aimed to feed on approximately 2000ppb LB, group II was designated 
the medium group of  approximately 1500ppb LB, Group III was the low group with 
approximately 1000ppb LB, and Group IV was designed as the control group which was 
fed less than 300ppb LB morning and evening. Feed samples were analyzed each week 
by HPLC-fluorescence analysis for LB and EV concentrations as described below.  
 
3.4 Sample collection and preparation.  
Fecal samples were collected once per day on days -7, -1, twice daily on days 0-3, 
once daily on days 4-7, then weekly for the duration of the trial (days 14-70). Fecal 
samples were obtained while steers were in a squeeze chute from the rectum. Samples 
were immediately placed into freezer bags on ice, and then transported to a chemical 
hood where they were spread on weight boats and allowed to air dry for 4-5 days. After 31 
 
drying, samples were stored at -20°C until analysis.  Dried feed, orts, and feces samples 
were prepared for HPLC-fluorescence and LC-MS/MS analysis by grinding in a Tecator 
1093 Cyclotec 1093 sample mill and passed through a 0.5mm screen.  Orts and feed 
samples were collected every day from each group; feces samples were pooled according 
to group and time point. All samples were submitted to the Endophyte Service 
Laboratory at OSU (ISO/IEC 17025, http://oregonstate.edu/endophyte-lab/) for 
quantitation of LB and EV.  
Solid phase extraction was then utilized for sample clean up. For LB, 0.200 g of 
dried, ground PRG straw, orts, or pooled feces was weighed out in duplicate, then turned 
in the dark for 18-24 hours at room temperature in 3ml of extraction solution 
(chloroform:methanol 2:1 (v/v)). The tubes were then centrifuged at 1,700 x g for 5 
minutes and 1.6 ml of the supernatant was transferred to clean glass culture tubes. The 
solvent was evaporated under a flow of nitrogen at ambient temperature. Two 1 ml 
additions of dichloromethane were used to dissolve the sample. CUSIL (United Chemical 
Technologies, Bristol, PA) SPE cartridges were loaded onto a positive pressure manifold 
and conditioned with 2 ml dichloromethane. The sample was then applied, followed by a 
2 ml dichloromethane wash. Next, a second wash of 0.5ml of elution solution 
(dichloromethane: acetonitrile 4:1 (v/v)) was added. LB and its metabolites were eluted 
with 3.0 ml elution solution which was captured and sealed for analysis. [20].  
For EV, solid phase extraction of dried, ground PRG straw, orts, and pooled feces 
was accomplished using a method adapted from Craig et al. (1994), Rottinghaus et al. 
(1990), and Hovermale et al. (2001). One gram of sample was added to 10 ml of 32 
 
chloroform, 1 ml internal standard (1µg/mL ergotamine tartrate) and 1 ml of 0.001 N 
NaOH. The tubes were capped and mixed for 18-24 hours in the dark. The tubes were 
then centrifuged at 1,700 x g and 5 ml of the supernatant was loaded onto Ergosil (United 
Chemical Technologies, Bristol, PA)
 SPE columns. The column was washed with 2 ml of 
acetone:chloroform (4:1 v/v) solution and EV and metabolites were eluted with 2.5 ml 
methanol. The eluate was collected, dried under nitrogen at 50 ºC and reconstituted with 
0.5 ml methanol. After sonication and mixing the extract was transferred to amber HPLC 
vial and sealed for analysis [20, 55, 56].  
 
3.5 HPLC-fluorescence analysis  
Analyses were performed using a Series 200 autosampler (PerkinElmer 
Instruments, Shelton, CT) coupled to an LS 40 fluorescence detector (Perkin Elmer). 
Data collection was completed using an interface to a PC-based data system which 
consisted of a 900 Series Interface and Total Chrom Workstation (PerkinElmer).  
 LB was detected using at an excitation wavelength of 268 nm and an emission 
wavelength of 440 nm. An analytical column Zorbax RX-SIL 4.6 x 250mm, 5-µm 
particle size (Agilent, Santa Clara, CA) was used in conjunction with a hand packed silica 
guard column. The mobile phase, dichloromethane-acetonitrile-purified water 
(400:100:2), was run isocratically at a flow rate of 0.5 ml/min.  Lolitrem B eluted at 8.3 
minutes with a total run time of 15 minutes. A standard curve was constructed from 
reference PRG material and then a linear regression fit of the peak height versus the 
amount of analyte injected was used to quantitate LB in unknown samples. 33 
 
For EV, the procedure was adapted from a previously described method [56]. 
Using a flow rate of 1.0 mL/min, separation was achieved via gradient elution using 65% 
H2O, 35% ACN, and 0.02% ammonium carbonate (mobile phase A) and ACN (mobile 
phase B) as follows:  0-3.5 minute 99%A:1%B; 3.5-5.5 minute a linear change to 35% 
A:65% B; 5.5-7.5 minute 30% A:70% B; 7.5-8.5 minute a linear change to 99% A:1% B; 
8.5-12 minutes 80% A:20% B. An analytical column packed with Gemini 4.6x 150mm, 
5-µ particle size was used in conjunction with a guard column cartridge with similar 
packing (Phenomenex, Torrance, CA). EV was detected using an excitation wavelength 
of 250 nm and an emission wavelength of 420 nm. EV eluted at 8 minutes and the 
ergotamine at 9 minutes with a total run time of 12 minutes. A standard curve was 
constructed from tall fescue reference material and a linear regression fit of the peak area 
versus the amount of analyte injected was used to quantitate ergovaline in unknown 
samples.  
 
3.6 Liquid chromatography-mass spectrometry analysis 
The LC-MS/MS system used consisted of a PerkinElmer Series autosampler, 
Perkin Elmer LC 200 micropump, a Peltier Series 200 cooling tray, and an AB 3200 Q 
TRAP system (Applied Biosystems, Foster City, CA). Both compounds were analyzed in 
positive ionization mode. LB and its metabolites were analyzed using atmospheric 
chemical ionization (APCI), while EV and its metabolites were analyzed with 
electrospray ionization (ESI). Multiple reaction monitoring (MRM) transitions were 34 
 
obtained using the quantitative optimization in Analyst 1.4.2; mass spectrometer settings 
are shown in table 3.1.  
TABLE 3.1 
Mass spectrometry parameters for metabolite identification and analysis of feces 
samples 
           
  Multiple Reaction Monitoring     Enhanced Mass Spectrum  
Parameter  Lolitrem B  Ergovaline    Lolitrem 
B 
Ergovaline 
Curtain Gas (psi)  30  10    30  30 
Nebulizer 
Current (µA) 
6  N/A
a    6  N/A
a 
Ion Spray 
Voltage (V) 
N/A
a  5000    N/A
a  5000 
Temperature (°C)  450  550    450  550 
Gas 1 (psi)  65  55    65  55 
Gas 2 (psi)  0  55    0  55 
Declustering 
Potential (V) 
61  36    25  20 
Entrance 
Potential (V) 
7  9    10  10 
Cell Exit 
Potential (V) 
4  4    N/A
a  N/A
a 
Collision Energy 
(V) 
51  85, 53, 41
b    10  10 
Q1  686.41  534.04    N/A
a  N/A
a 
Q3   196.3, 237.9, 
628.4 
207.0, 208.1, 
223.1 
  N/A
a  N/A
a 
aParameter not required in specific method of analysis.  
bCollision energies are listed in the same order as their respective Q3 values.  
 
The HPLC settings were as follows: for LB a Prodigy ODS(30), 5 µ, 150 x 4.6 
mm (Phenomenex, Torrance, CA, USA) column was used with  40% acetonitrile in 
water, 0.1% acetic acid (mobile phase A) and acetonitrile with 0.1% acetic acid (mobile 
phase B) flowing at 0.65mL/min at a gradient as follows: held for 5 minutes at 20% B 35 
 
then raised linearly to 100% B over 5 minutes and held for 5 minutes before finishing at 
20% B. For EV the same column and mobile phases as described above for HPLC-
fluorescence quantitation of EV were used. However, the gradient profile was altered 
such that the system was held for 5 minutes at 99% A then decreased linearly to 35% A 
over 10 minutes and held at 35%A for 2 minutes before equilibrating for 6 minutes at 
99%A.  
Potential metabolites in feces were identified using an enhanced mass spectrum, 
independent data acquisition, and enhanced product ion scans (EMS IDA EPI) method 
with the same equipment and mobile phases mentioned previously for the MRM 
methods.  HPLC conditions were the same except for the gradient used. For LB the 
gradient was as follows: 10 minutes at 100%A, then raised linearly to 100% B over 55 
minutes and held at 100%B for 5 minutes before re-equilibrating at 100%A for 5 minutes 
at a flow rate of 0.65 mL/min.  For EV, the gradient was as follows: 2 minutes at 99% A, 
linearly decreased to 35%A over 60 minutes, held at 35%A for 5 minutes and 
equilibrated again at 99%A for 5 minutes.  
The EMS experiments for LB were conducted using a scan of all ions in the mass 
ranges of 150-630 and 625-1500 amu using a cell exit potential (CEP) of 5.54 V. An EPI 
(MS/MS) scan was triggered for ions greater than 1000 counts. The EMS scans for EV 
were done in two ranges of 100-280 and 275-1500amu with CEPs of 4.74 and 7.54 V, 
respectively. For both toxins, EMS parameters were the same for EPI except three EPI 
experiments were done with different collision energies of 47, 61, and 63. All CEP values 
for EPI experiments were 3.62. Additional settings are shown in Table 1. An EPI scan of 36 
 
1.46 µM LB in ACN and 1nM  EV standard using this LC-MS/MS method are shown in 
figure 1.    
Metabolite screening and identification was conducted using Lightsight Software 
Version 2.0 (Applied Biosystems).  
 
3.7 Statistical analysis. 
 Statistical analysis of all HPLC-fluorescence and LC-MS/MS data was done 
using a one way analysis of variance (ANOVA) followed by a Bonferroni’s test  
(GraphPad Prism 5.0 , GraphPad Software, La Jolla, CA). Metabolite Q1/Q3 transitions 
obtained from EMS IDA EPI and Lightsight were added to the respective MRM method. 
From the MRM peak area , a semi-quantitative analysis of metabolites was accomplished. 
Epimers eluting with the same retention times as to ergovaline and its epimer, the peak 
areas were added together. For determination of a linear relationship between LB and 
EV, the concentrations of LB and EV in feces were compared across all groups using a 
Pearson’s test of correlation to determine coefficients.  
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Chapter 4. Results 
4.1 Animal Health and Staggers 
            The average body weight for each group increased linearly with R
2 values of 0.72, 
0.93, 0.88, 0.89 respectively for Group I-IV. One way ANOVA showed an P value of 
0.0069 (GraphPad Prism 5.0 , GraphPad Software, La Jolla, CA).  Bonferroni’s multiple 
comparison test showed P <0.05 when group I was compared to groups III and IV.  
  Feed consumption was measured in pounds by adding the amount of hay and 
grain given to each group and subtracting the orts in pounds measured the following 
morning. Feed consumption was monitored a total of 71 times before and during the 
experiment. One way ANOVA of lbs of feed consumed showed a P < 0.0001 across all 
four groups. Bonferroni’s multiple comparison tests showed P < 0.05 for group I vs II & 
III, group II vs III & IV, and group III vs IV.   
  On day 24 of the experiment an increase in diarrhea was noticed and one steer 
from each group was tested for Coccidia parasites using a fecal floatation test at the 
Oregon State University Veterinary Diagnostic Laboratory (Corvallis, OR). Group I 
showed no oocysts or eggs, Group II, III, and IV showed 125, 50, and 675 oocysts per 
gram of feces, respectively. 
  
4.2 Perennial Ryegrass and Orts Quantitation by HPLC-Fluorescence 
  Table 4.1 shows the results of LB and EV concentration in the feed for each 
group. For both EV and LB, one-way ANOVA analysis with a Bonoferroni’s correction 38 
 
gave P<0.0001 and P <0.05, respectively. Thus, feed concentrations of EV and LB were 
different between all four groups.  
HPLC-fluorescence quantitation of the feces showed significant differences 
between groups for LB concentration (P value < 0.0001, Figure 2A). was sampled a total 
of 70 times and averages for both EV and LB during the entire experiment are shown in 
table 2. For both EV and LB, one way ANOVA analysis followed by Bonoferroni’s post 
test showed P< 0.0001 and P<0.05, respectively. This showed that the concentrations for 
EV and LB were statistically different for all groups.  
Table 4.1: Average concentration of lolitrem B and ergovaline in perennial ryegrass 
feed and orts determined by HPLC-fluorescence. 
             
             
Group  Lolitrem B in 
perennial 
ryegrass (ng/g)ᵃ 
Lolitrem B 
in orts 
(ng/g)ᵃ 
p 
valueᵇ 
Ergovaline 
in perennial 
ryegrass 
(ng/g)ᵃ 
Ergovaline 
in orts 
(ng/g)ᵃ 
p 
valueᵇ 
I  2256 ± 166  2484 ± 348  0.0169  638 ± 77  741 ± 49  < 
0.0001 
II  1554 ± 213  1598 ± 263  0.4821  373 ± 119   463 ± 167   0.0961 
III  1012 ± 197  1793 ± 212  0.0015  259 ± 53  357 ± 58  0.0002 
IV  247 ± 175  211 ± 138  0.3111  <100  <100  N/A 
             
ᵃResults reported as mean ± standard deviation (n=60)     
ᵇResults from students t-test comparing concentrations of lolitrem B and ergovaline in 
perennial ryegrass feed and orts.  
 
4.3 Feces Samples Quantitation by HPLC-Fluorescence 
  HPLC-Fluorescence data showed significant differences between groups in LB 
concentration (P value <0.0001). Group I showed peak LB concentrations on days 3 PM 
(2743 ppb), 7 (3065 ppb), 25 (3502 ppb), 49 (3877 ppb), and 56 (4297 ppb). Group II 
showed similar maximum concentrations on days 3PM (2200ppb), 6 (2227ppb), 28 39 
 
(3323ppb), and 53 (3213ppb). Group III (1012ppb) showed maximum concentrations on 
days 3AM (1324 ppb), 14 (2344 ppb), and 49 (2454 ppb) while group IV (247 ppb) 
showed maximum concentrations at day 3PM (1209 ppb), 7 (1071 ppb), 49 (741 ppb), 
and 56 (690 ppb). Concentration curves of LB in feces by group is shown in figure 5A. 
The LB concentration for group I was not completely eliminated during the one week 
inadvertant washout period, but it did decline to the level seen in group III.   
  Quantitation of EV by HPLC-fluorescence detection in bovine feces showed 
statistically different concentrations for all groups (p <0.0001, Figure 4.1). All fecal 
samples for Group III showed values of EV <100ppb, while group I showed peak EV 
concentrations on days 2 PM (293 ppb), 6 (353 ppb), 14 (483 ppb), and 42 (481 ppb); 
group II showed peak EV concentrations on days 2 AM (174 ppb), 4 (232 ppb), 28 (389 
ppb), 49 (436 ppb). Group IV showed peak EV levels on days 2AM (140 ppb), 5 and 6 
(201 ppb), 14 (246 ppb), and 42 (280 ppb). During the one week washout period for 
group I levels of EV did decrease to the levels seen for group III. 
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Figure 4.1 Lolitrem B and ergovaline concentrations (ppb) in feces by HPLC-fluorescence. Group IV 
EV levels were below the limit of quantitation. For each group, 6 feces samples for group I, III, and IV and 
5 samples for group II, were pooled and analyzed in duplicates by HPLC-fluorescence. 
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4.4 LC-MS/MS Feces Metabolite Analysis 
  Using the EMS-IDA-EPI and MRM LC-MS/MS methods previously described 
for LB, possible metabolites were identified using product ions found in the 
fragmentation of LB standard (Figure 4.2), specifically m/z 196 and 238.  41 
 
 
Figure 4.2. Structure and fragmentation pattern of lolitrem B. 
Lightsight analysis was used to help identify additional metabolites. This software 
provides lists of possible metabolites based on common losses, common product ions, 
and matching molecular ion peaks to common metabolites based on parent molecule. 
Through Lightsight analysis, peaks consistent with an m/z of 603.4, 669.4, 672.4, 687.4, 
688.4 and 702.4 were detected in multiple samples and showed fragmentation to the 196 
and 238, daughter ions common to LB (Appendix A). This information was used to 
create a more tailored MRM method in order to identify trends in these metabolites. Peak 
areas were obtained for each of the compounds: a semi-quantitative analysis showed that 
there were significant differences in peak area between all four feeding groups for peaks 
consistent with  m/z 687.4, 688.4, and 702.4 (p <0.0001, Table 4.3). The metabolite m/z 
688.4 eluted at two difference times 12.6 and 13.2 minutes; peak areas of both peaks 
showed a significant difference between all four groups (p < 0.0001). Upon further 
investigation with Light Sight, possible metabolites identified through MS/MS (Appendix 42 
 
A) are consistent with deamination and reduction, and/or amine hydrolysis, 
demethylation and oxidation or hydrogenation, and oxidation (m/z 702.4). Possible 
structures for m/z 688.4 are shown in Appendix E based on literature of known 
metabolism of 3-MI.  Bonferroni’s multiple comparison test results (table 4.2) show the 
significance is the greatest between all groups when looking at m/z 702.4   
Table 4.2 
Bonferroni's Multiple Comparison Test of Lolitrem B metabolites from MRM peak area 
analysis 
  m/z 688.4 (13min)  m/z 688.4 (12 min)  m/z 687.4  m/z 702.4 
  P < 0.05    P < 0.05    P < 0.05    P < 0.05   
I vs II  No  ns  No  ns  No  ns  No  ns 
I vs III  Yes  **  Yes  *  Yes  *  No  ns 
I vs IV  Yes  *  Yes  *  Yes  *  Yes  *** 
II vs III  Yes  ***  Yes  ***  Yes  **  No  ns 
II vs IV  No  ns  No  ns  No  ns  Yes  *** 
III vs IV  Yes  ***  Yes  ***  Yes  ***  Yes  *** 
 
 
Table 4.3 
Lolitrem B metabolites determined by enhanced mass spectra and Lightsight analysis 
             
Parentᵃ  Common 
Fragmentsᵃ 
Proposed Biotransformation(s)ᵇ   Q1/Q3ᶜ  p Valueᵈ 
702.12  644.2, 238.1, 
196.1 
oxidation  702.4/237.9  <0.0001 
687.52  629.3, 571.2, 
238.1, 237.1 
deamination, reduction AND/OR 
primary amide hydrolysis 
687.4/237.9  <0.0001 
688.4 
(a) 
630.0, 238  demethylation, oxidation AND/OR 
hydrogentation 
688.4/237.9  <0.0001 
688.4 
(b) 
630.0, 238  demethylation, oxidation AND/OR 
hydrogentation 
688.4/237.9  <0.0001 
             
ᵃIdentified using enhanced mass, independent data acquisition, and enhanced product ion scan (EMS IDA 
EPI).  
ᵇProposed biotransformation obtained using Lightsight version 2.0. 
ᶜTransitions obtained from EMS IDA EPI method and then used in multiple reaction monitoring method 
(MRM) to obtain peak areas for statistical analysis. 
ᵈValues calculated using peak areas obtained from transition in Q1/Q3 column, one way analysis of 
variance, and Bonferroni's post test.  43 
 
 
Figure 4.3 Shows a sample MRM of Loltirem B metabolites identified by EMS IDA EPI and Lightsight.  
Using the EMS-IDA-EPI and MRM LC-MS/MS methods described above for 
EV, possible metabolites were identified using the common and most abundant ergot 
alkaloid product ions of m/z 208 and 223. The structure in figure 4.3 shows the common 
site of fragmentation that gives m/z 223 and 208. [57]. Secondary and less abundant ions 
used for identification were m/z 249 and 516. All possible metabolites obtained using the 
EMS IDA EPI method are shown in table 4.5. From this data MRM transitions were 
added to the method already used for EV MRM analysis, in order to conduct a semi-
quantitative analysis using peak area and ANOVA. Additionally, Q1/Q3 values used for 
semi-quantitative analysis are also shown in table 4.5. 44 
 
 
Figure 4.4. Structure and fragmentation pattern of ergovaline. 
The possible metabolite of m/z 564 was seen only in group IV (<100 ppb EV). 
However, this is also a common fragment of ergotamine which was used as an internal 
standard. However, since it is predominately present in group IV it is also possible that 
the ion is in fact the oxidation to acid of a methyl group on ergovaline [58]. Certain 
metabolites showed epimer peaks similar to ergovaline (2 peaks), however an epimer for 
the purpose of this study was only used when the retention times matched those of EV 
parent and its epimer. Figure 9 also shows that m/z 550 and 532 show a total of 4 peaks 
suggesting 2 epimers and possible phase II metabolism. It should also be noted that there 
are noticeable multiple peaks for metabolites suggesting ion source fragmentation and 
phase II metabolism. From the MS/MS (Appendix B) obtained for the metabolites 516, 
532, 536, 55, 564, and 566 it can be shown that metabolism is most likely occurring on 45 
 
rings 5,6, and 7 of the structure shown in figure 2B. This is shown by the common 
fragments of 223 and 208 being retained in most cases.  
 
Table 4.4 
Bonferroni's Multiple Comparison Test For Ergovaline Metabolites from MRM peak area analysis. 
m/z  598.8  516  532  535/224 
  P < 0.05  Summaryᵃ  P < 0.05  Summaryᵃ  P < 0.05  Summaryᵃ  P < 0.05  Summaryᵃ 
I vs II  No  ns  No  ns  Yes  ***  No  ns 
I vs III  Yes  *  Yes  ***  Yes  ***  Yes  *** 
I vs IV  Yes  ***  Yes  ***  Yes  ***  Yes  *** 
II vs III  No  ns  No  ns  No  ns  No  ns 
II vs IV  Yes  ***  Yes  ***  Yes  ***  Yes  *** 
III vs IV  No  ns  Yes  **  Yes  ***  Yes  ** 
m/z  534.8/224  537  539  535/223 
  P < 0.05  Summaryᵃ  P < 0.05  Summaryᵃ  P < 0.05  Summaryᵃ  P < 0.05  Summaryᵃ 
I vs II  No  ns  Yes  *  Yes  *  Yes  * 
I vs III  Yes  ***  Yes  ***  Yes  ***  Yes  *** 
I vs IV  Yes  ***  Yes  ***  Yes  ***  Yes  *** 
II vs III  No  ns  Yes  *  Yes  **  No  ns 
II vs IV  Yes  ***  Yes  ***  Yes  ***  Yes  *** 
III vs IV  Yes  ***  Yes  ***  Yes  **  Yes  * 
m/z  816.9  610.8  552  611.9 
  P < 0.05  Summaryᵃ  P < 0.05  Summaryᵃ  P < 0.05  Summaryᵃ  P < 0.05  Summaryᵃ 
I vs II  No  ns  No  ns  No  ns  No  ns 
I vs III  Yes  **  Yes  ***  Yes  **  No  ns 
I vs IV  No  ns  Yes  ***  No  ns  No  ns 
II vs III  Yes  **  Yes  ***  Yes  **  Yes  *** 
II vs IV  No  ns  Yes  ***  No  ns  No  ns 
III vs IV  No  ns  No  ns  No  ns  No  ns 
m/z  802.9  824.7  550  596.8 
  P < 0.05  Summaryᵃ   P < 0.05  Summaryᵃ  P < 0.05  Summaryᵃ  P < 0.05  Summaryᵃ 
I vs II  No  ns  No  ns  Yes  ***  No  ns 
I vs III  No  ns  Yes  **  Yes  ***  Yes  ** 
I vs IV  Yes  ***  ------  ------  Yes  ***  Yes  *** 
II vs III  No  ns  No  ns  Yes  *  Yes  ** 
II vs IV  Yes  **  ------  ------  Yes  ***  Yes  *** 46 
 
III vs IV  No  ns  ------  ------  Yes  ***  No  ns 
ᵃIndicates how significant the differences were between the groups( ns = not significant). More “*” 
indicates stronger significance.  
Table 4.5 
Ergovaline metabolites determined by enhanced mass spectra and Lightsight analysis 
               
Parentᵃ  Common Fragmentsᵃ 
Proposed 
Biotransformation(s)ᵇ  Q1/Q3ᶜ  p Valueᵈ 
Possible 
Epimersᵉ 
492ᶠ  225, 239, 251  tri-demethylation       
516  249, 223  dehydration  516/223  <0.0001  + 
532  249, 221  dehydrogenation  532/221  <0.0001   
535  (A) 224, 209 (B) 223, 
208 (C) 224, 208 
deamination, reduction 
AND/OR primary amide 
hydrolysis 
(A) 534.8/224  (B) 
535.1/223 (C) 
535.1/224 
(A) 
<0.0001 
(B) 
<0.0001 
(C) 
<0.0001 
+ 
536  223, 209  demethylation, oxidation 
AND/OR hydrogenation  536/223  <0.0001  + 
537  509, 437  Unknown  537/437  <0.0001   
539  450.8, 479.9  Unknown  539/450.8  <0.0001  + 
550  249,221,208  oxidation  550/221  <0.0001   
552ᵍ  534, 523  hydrolysis  551.9/533.9  0.0007   
564
h  223, 208  oxidation (CH3) to acid 
(COOH)      + 
566ᶠ  223  dioxidation       
596.8  569, 537, 209 
loss of cyclohexyl ring, 
oxidation, glutamine 
conjugation AND/OR loss 
of NH3, sulfonation 
596.8/568.7  <0.0001  + 
598.8  570.7, 538.9  tri-demethylation and 
taurine conjugation  598.8/570.7  <0.0001   
610.8  551, 533, 249  Unknown  610.8/532.9  <0.0001   
611.9ᵍ  594, 534 
loss of H2O, oxidation, 
and sulfonation AND/OR 
di-keto, tri-oxidation 
611.9/533.9  0.0001   
615ᶠ  551, 175  sulfonation       
802.9  363, 292, 226, 207  loss of cyclohexyl ring  
and bis-glucuronidation  802.9/363  0.0002   
816.9  562, 256 
loss of cycohexyl ring, 
dioxidation, CO, and 
glutathione conjugation 
816.9 / 256.1  0.0008   
824.7ᵍ  726, 563  loss of NH3 and 
glutathione conjugation  824.7 / 563.0  0.02   
841ᶠ  823, 223  glutathione conjugation       
ᵃIdentified using enhanced mass, independent data acquisition, and enhanced product ion scan (EMS IDA EPI). 
ᵇProposed biotransformation obtained using Lightsight version 2.0. 
ᶜTransitions obtained from EMS IDA EPI method and then used in multiple reaction monitoring method (MRM) 
to obtain peak areas for statistical analysis. 
ᵈValues calculated using peak areas obtained from transition in Q1/Q3 column, one way analysis of variance, and 
Bonferroni's post test. 
ᵉPossible epimers indicated with a “+” because of matching retention times to ergovaline and its epimer. 
ᶠNot enough data  to compare all groups. 
ᵍNot enough data for group III (control) 
hOnly identified in group III and very little in group I 47 
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Figure 4.5 Shows a sample MRM developed for EV metabolites using the MS/MS data obtained in the 
EMS IDA EPI method. 
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Chapter 5.  DISCUSSION 
5.1 Animals  
The results of the clinical trial showed that both groups I and II developed clinical 
signs of ryegrass staggers during the course of the 56 day feeding experiment. This is in 
contrast with previous findings that LB at a dose of 1500ppb does not cause ryegrass 
staggers [59]. The possible factors influencing this outcome could be age, time of year, 
and rumen microbiota.   
 
5.2 Feed intake and weight gain 
Ergot alkaloids have been associated with decreased feed intake and average daily 
weight gain [60]. In this study the average weight gain of group I compared to group III 
and IV did show small statistically significant differences. Alkaloids from both PRG and 
tall fescue have been studied in relation to their effect on weight gain. Some studies have 
found that weight gain and feed intake do not differ with varying alkaloid concentrations.  
A study done during winter months did conclude that weight gain and feed intake did not 
differ [61]. The results in this study showed from the feed intake monitoring all four 
groups did show differences in feed intake; however, there was no significant difference 
between the feed intake of group I and group IV, high and control respectively.  
 
5.3 Coccidia Tests 
The results of the unplanned coccida fecal flotation tests are intriguing and 
suggest a need for future studies designed to look specifically at this effect. Group I 49 
 
(2256 ppb LB/ 638 ppb EV) showed no oocysts while group IV, the group consuming the 
least amount of LB and EV showed the most oocysts per gram of feces. Thus, it appears 
that increased alkaloid concentration in the feed may actually inhibits growth of coccidia. 
Coccidia is a common problem in young calves which also associated with diarrhea and 
reduced weight gain [62]. Calves that are more at risk usually become infected with 
coccidia parasites after being grouped together or moved into a contaminated 
environment[63]. The decreased weight gain seen in our study could have been 
complicated by this factor. In Girgis, et. al., (2010) effects of Fusarium mycotoxins in 
were studied with a coccidia challenge given initially and at 4 weeks of age after 
receiving between 0.5-6.5 µg/g of deoxynivalenol (DON), 15-acetyl-DON and 
zearalenone which were present in a naturally contaminated chicken feed. This study 
showed naturally contaminated feed did have the potential to modulate the immune 
system response to coccidial infections. [64-68]. The potential for EV or LB to act as 
anti-protozoa compounds has not been explored.  
 
5.4 HPLC-Fluorescence Feed and Feces Data 
Investigation into a linear relationship between LB and EV in PRG was repeated 
according to Hovermale et. al. (2001). Briefly, a linear regression and Pearson tests were 
performed resulting in an R
2 value and Pearson coefficients, Groups I, II, III showed 
R
2/Pearson coefficients of values  0.7965/0.834, 0.4213/0.902, and 0.3731/0.776 
respectively (group IV had no detectable EV and so was not analyzed). The R
2 values 
demonstrate that the linear relationship between LB and EV is strongest at high 50 
 
concentrations. The R
2 value calculated previously was 0.7335; thus, both studies show a 
similar relationship between the toxins despite their being performed ten years apart [69]. 
The Pearson coefficients are all very close to +1 indicating a linear equation describes the 
relationship of EV and LB most accurately in PRG samples.  
When examining the LB and EV linear relationship in feces, groups I, II, and III 
showed R
2/Pearson coefficients of 0.8193/0.834, 0.8727/0.902, and 0.6778/0.776, 
respectively. The Pearson coefficients appear to be similar to the PRG straw, but the R
2 
values in the feces seem to be more consistent across dose groups. In summary, however, 
the linear relationship between the two toxins appears to carry over from feed to 
excretion. Fecal sample quantitation by HPLC-fluorescence did show similar patterns to 
the amount of either LB/EV in the feed; those fed the highest amount of alkaloids 
excreted the highest amount of LB/EV in the feces (Figure 4.1).  Over the one week 
washout, LB levels in the feces dropped from 3000 ppb to 2000 ppb LB then quickly 
rebounded to 3000 ppb after return to 2256 ppb LB in the feed. EV levels dropped from 
500 to 200 ppb and took one more week to regain previous levels in the feces (450 ppb). 
For fecal excretion of LB, group II did reach the same concentration as that seen in group 
I, which helps explain why staggers were observed in those two groups, while groups III 
and IV showed no clinical signs and feces LB levels remained below 2000 ppb for the 
duration of the experiment. Analysis of serum, urine, and fat samples from this study 
need to be completed; this will allow for a more extensive toxicokinetic evaluation of 
these two compounds. However, previous research suggests that feces are likely the 
primary route of excretion for EV, as it was found in the pictogram level in serum of 51 
 
horses [70]. Measuring lysergic acid excretion in the urine will also help to determine if 
feces are the primary route of excretion [71].  
 
5.5 Fecal analysis by LC-MS/MS 
Metabolite analyses of the feces by mass spectrometry showed that the same types 
of products were excreted for both LB and EV. Specifically, m/z values that match 
potential metabolites of oxidation, deamination & oxidation, amide hydrolysis, 
hydrogenation, or demethylation & oxidation were detected. The only difference was no 
m/z value to indicate hydrogenation or dehydrogenation for LB was detected, only 
possible metabolites for EV. When both oxidation metabolites for EV and LB, m/z 550 
and 702.4 respectively, were compared using a one way ANOVA analysis followed by 
Bonoferroni’s posttest, m/z 550 showed p<0.0001 for ANOVA and p < 0.05 for post-test 
of all groups. The LB oxidation metabolite m/z 702.4 also showed overall p < 0.0001 for 
one way ANOVA. Both oxidation metabolites showed common fragments m/z 196 and 
238 for LB, and m/z 223 and 208 for EV. A proposed route of formation of m/z 702.4 
based on ruminant metabolism of 3-methylindole is shown in figure 5.1 and 5.2 [47]. 
Ergot alkaloids are not commonly associated with the upregulation of glutathione 
synthesis to help in detoxification, however 3-methylindole is known to form GSH 
conjugates as a method of detoxification. The role of glutathione in the detoxification of 
EV and LB should be examined further because of the stability proposed in 3-MI 
metabolism and the upregulation of glutathione-S- transferase in Tanaree, et. al. (2012). 
Glutathione could offer an explanation to why LB clinical signs are seen and not EV 52 
 
when both toxins are consumed together. An ion m/z 841 was detected and fragmentation 
showed m/z 223, which could be a GSH conjugation of EV[43, 47]. Lehner et al. (2004) 
showed the common fragments of a number of ergot alkaloids and upon examination of 
current data that MS/MS spectra seen with the fragments m/z 223 and 208 are metabolites 
of ergovaline because the parent masses do not correlate to other known ergot alkaloids 
or mycotoxins [31, 58].  
Peak areas obtained from MRM data was used to determine the linear relationship 
and Pearson Coefficients between EV and LB. Group I, II, III, and IV showed R
2/Pearson 
Coefficient values of 0.7641/0.874, 0.7563/0.870, 0.7607/0.872, and 0.7939/0.891 
respectively. Not only is EV and LB being consumed at a linear relationship at high 
concentrations, it is being excreted in the feces with a stronger linear relationship. Since 
all of the LB metabolites showed fragments of m/z 238 or 196 we conclude that 
metabolism is happening most likely at rings 3, 4, and 5 on the lolitrem B structure in 
figure 2.2. The MS/MS obtained for the metabolites m/z 516, 532, 536, 535, 564, and 566 
suggests that metabolism is most likely occurring on rings 5,6, and 7 of the structure 
shown in figure 2.1. This is shown by the common fragments of 223 and 208 being 
retained in most cases. This was also proposed in Lehner et al. (2004) for a dehydrated 
metabolite of ergocrystine where the moiety responsible for m/z 223, and 208 is retained 
during metabolism and the hydroxyl group between rings 5 and 6 is removed. [57] 
The oxidation and reduction metabolites identified in the feces do correspond 
with previous findings of ergot alkaloid metabolism which concluded that cytochrome 
P450 enzymes are up regulated and genes associated with anti-oxidant pathways are 53 
 
down regulated [43, 72-75] . Several ergot alkaloids used in human medicine are known 
CYP3A4 substrates and drug-drug interactions can be expected [76]. To our knowledge 
there is no data relating LB metabolism and upregulation of CYP450 enzymes except for 
one unpublished experiment conducted by this laboratory which found that genes 
associated with oxidation and reduction are up-regulated which corresponds to the 
potential metabolites identified previously. Lanza, et al. (2001) did provide a detailed 
experiment identifying the certain CYP 450 enzymes responsible for the metabolism of 
3-MI. Based on this information, figure 5.3 shows a proposed metabolism pathway of LB 
based on the known CYP 450 metabolism of 3-MI. This proposed pathway again 
provides more possible routes to form m/z 702.4. CYP 2E1 and 3A4 were very selective 
in the metabolism of 3-MI and was also proposed as a route of detoxification for ergot 
alkaloids [43, 48]. Interestingly, dehydrogenation has been proposed as a route of 
metabolism for 3-MI yet we did not find anything that suggested dehydration for LB. 
Conversely, possible dehydration and dehydrogenation metabolites were identified in EV 
samples. Since CYP 2F1 and 2F3 were found in Lanza et al. (2001) to selectively 
metabolize 3-MI to the dehydrogenation metabolite, an in vitro study comparing the EV 
and LB metabolism would help understand possible competitive inhibition.  This 
provides a new hypothesis that EV disease symptoms are not seen due to competitive 
inhibition through CYP2E1, 2F1, 2F3, and/or 3A4. 
One detail that should be noted is that the LB metabolites identified also 
correspond to m/z values of other lolitrems [37]. The MS/MS generated fragmentation 
patterns for these lolitrems were not accessible to verify the identity of the peaks. 54 
 
However, the statistical differences seen in the LC-MS/MS data matches that of the 
HPLC-fluorescence feed concentrations of LB and EV. Additionally, the two peaks 
identified as m/z 688.4 showed statistically significant peak areas across all groups and 
suggests that these ions are metabolites of LB. The ion with m/z 688.4 eluted at two 
different times proposed structures are shown in Appendix E and MS/MS is shown in 
Appendix A. 
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Figure 5.1. Proposed lolitrem B metabolism in bovine species also consuming ergovaline based on the 
previously reported metabolism of 3-MI in ruminants in Noccerini (1985).  
 56 
 
 
Figure 5.2. Proposed metabolism by CYP 450 enzymes based on the 3-MI metabolites in Lanza, et al 
(2001). Brackets represent molecules that were not detected. 
 
5.6. CONCLUSION 
The findings in this study supported the findings in Hovermale et.al.,(2001)  and 
also showed that EV and LB are excreted in the feces in a linear relationship. From the 
LC-MS/MS data we can improve the understanding of LB. Data in this study suggest that 
LB is most likely metabolized by CYP450 enzymes. The idea that these two toxins are 
similarly metabolized leads to the need for further studies specifically those using 
enzymes. Genomic and microsomal assays would help to confirm the up regulation of 
CYP450 enzymes while metabolomics studies would help understand what anti-oxidant 57 
 
pathways are being activated. More research is needed to determine the clinical disease 
impact that results from ingesting these two compounds together. Mixtures of mycotoxins 
are only beginning to be studied and understanding the synergistic effects will greatly 
influence how disease from these two  toxins are treated in clinical cases.  
Additionally, high resolution mass spectrometry would also help to confirm these 
metabolites.  
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Appendices 
Appendix A. MS/MS of possible lolitrem B metabolites. MS/MS of potential LB metabolites identified 
through EMS IDA EPI method using APCI (+).(A) Shows LB identified in feces and (B) Shows possible 
oxidation metabolite of m/z 702.2 ( C) Shows the possible hydrogenation metabolite and/or demethylation 
and oxidation metabolite. (D) Shows the possible deamination and reduction metabolite of m/z 688.4. 
 +EPI (686.20) Charge (+1) CE (47) FT (250): Exp 2, 27.160 min from Sample 1 (Gr... Max. 5.7e4 cps.
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 +EPI (688.38) Charge (+0) CE (47) FT (50): Exp 2, 44.025 min from Sample 3 (Grp... Max. 5.0e4 cps.
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Appendix B. MS/MS of possible ergovaline metabolites. Shows the MS/MS of potential EV metabolites 
identified through EMS IDA EPI method using ESI (+). 
 +EPI (538.98) Charge (+1) CE (61) FT (250): Exp 4, 8.76... Max. 1.0e5 cps.
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 +EPI (531.89) Charge (+0) CE (47) FT (250): Exp 2, 11.5... Max. 5.7e4 cps.
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 +EPI (610.89) Charge (+0) CE (47) FT (250): Exp 2, 21.0... Max. 2.3e4 cps.
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 +EPI (824.94) Charge (+0) CE (63) FT (250): Exp 3, 34.0... Max. 3.3e4 cps.
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 +EPI (566.93) Charge (+1) CE (47) FT (250): Exp 2, 13.3... Max. 2.3e4 cps.
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 +EPI (534.85) Charge (+1) CE (47) FT (250): Exp 2, 14.2... Max. 7.0e4 cps.
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 +EPI (596.80) Charge (+3) CE (47) FT (250): Exp 2, 23.1... Max. 1.0e5 cps.
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 +EPI (552.88) Charge (+1) CE (47) FT (250): Exp 2, 14.4... Max. 4.1e5 cps.
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 +EPI (840.91) Charge (+0) CE (63) FT (250): Exp 3, 34.0... Max. 1.0e4 cps.
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 +EPI (537.02) Charge (+0) CE (47) FT (250): Exp 2, 22.0... Max. 1.2e5 cps.
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 +EPI (563.94) Charge (+1) CE (47) FT (250): Exp 2, 19.7... Max. 3.7e5 cps.
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 +EPI (614.86) Charge (+1) CE (47) FT (250): Exp 2, 26.4... Max. 1.0e4 cps.
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Appendix C. Semi-quantitative graphs of LB metabolites using MRM peak areas and Graphpad Prism 
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Appendix D. Semi-quantitative graphs of EV metabolites using MRM peak area and Graphpad 
Prism.
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Appendix E. Lolitrem B Metabolite Structures. Possible LB metabolite structures based on MS/MS and 
known fragmentation pattern of LB 
 